TriAxiaHealth

Improving health outcomes for patients living with rare disease by enabling the selection and discovery of the most effective treatment for each patient

[TriAxiaHealth @TriAxiaHealth]

In addition to her training in public health, Ms. Barry brings her experience as a patient with Pulmonary Arterial Hypertension (PAH or Group 1 Pulmonary Hypertension) to this important work. Her research interests have shifted to pulmonary hypertension following her diagnosis.

[TriAxiaHealth @TriAxiaHealth]

Ms. Barry moderates for the Pulmonary Vascular Research Institute, as well as manages a Sotatercept (Winrevair) forum. She previously worked in personalized medicine research at Mass General Brigham.

[TriAxiaHealth @TriAxiaHealth]

TriAxia Health is pleased to announce that Katrina Barry, MPH, has joined us as a research intern. Ms. Barry will be working with VP Data and Analytics Vladimir Valtchinov on our research on using AI and clinical data, including imaging, to diagnose Pulmonary Hypertension.

[TriAxiaHealth @TriAxiaHealth]

Very proud to be working with Katrina as she not only fights PAH, but contributes to research on it with us!
#pah #RareDisease
https://t.co/KEzqnNaXq1

[TriAxiaHealth @TriAxiaHealth]

VERY proud to announce that we have hired leading clinical data scientist Vladimir I. Valtchinov (not on twitter) as our new VP of Data & Analytics!

[SSI Strategy @SSIStrategy]

Did you know that #clinicaltrials dot gov has an API? More facts about the site from @Lilly_COI: http://t.co/dw8GkI2v6z #pharma

[SSI Strategy @SSIStrategy]

We are thrilled to announce the opening of our new SSI location in Cambridge, Massachusetts! In the area? Let us know how we can help!

[TriAxiaHealth @TriAxiaHealth]

We're hiring! Looking for both a data engineer experienced with structured clinical data/FHIR, AI, and advanced analytics and a bioinformatacist! Email [email protected] for JDs #hiring #dataengineer #bioinformatics

[TriAxiaHealth @TriAxiaHealth]

#TriAxiaHealth is #hiring! Seeking a Director of Bioinformatics to help us in our #RareDisease #Genomics work - see https://t.co/gRgOOxGBqZ for details

[TriAxiaHealth @TriAxiaHealth]

@ashishkjha @EricTopol You do have to wonder about the 4%, though...

[TriAxiaHealth @TriAxiaHealth]

Very proud to share our post from #ATS - not sure how well it will survive twitter so DM us if you want the original

[TriAxiaHealth @TriAxiaHealth]

@EricTopol @NatureGenet AS the father of twins, this explains a lot...

[ixlayer @ixlayer_]

We HAVE a scalable digital solution for vaccine distribution including reporting, scheduling, dose reminders, adverse event reporting, etc. This can be deployed within all health systems and retail settings. Let us help @PeterHotez @ScottGottliebMD @ASlavitt

[TriAxiaHealth @TriAxiaHealth]

Proud to announce that our CEO, Simon Kennedy, has joined the board of @SSIStrategy, a leading life-sciences consultancy with a focus on rare disease and gene therapy, as part of the investment made by Amulet Capital
https://t.co/ynKda3hqrQ

[TriAxiaHealth @TriAxiaHealth]

"... with the best machine learning algorithm, I would take A any day of the week over B.". Congrats on making the Endpoints 11! (2)
https://t.co/G19rH2xG3z

[TriAxiaHealth @TriAxiaHealth]

We strongly agree with @insitro CEO @DaphneKoller : "…those of us who have been working in machine learning for a very long time know that given the option between a really great data set with a relatively straightforward machine learning algorithm versus a crappy data set...(1)

[Gary Schroth @Genomics_Guy]

👏🏼👏🏼👏🏼
Nobel Prize in chemistry awarded to two women who developed CRISPR, the revolutionary gene-editing tool https://t.co/k45Uj4vlK3

[Juno Bio @wearejunobio]

Need 1 reason to learn more about the vaginal microbiome? How about 30? A disrupted #vaginalmicrobiome has been associated with over 30 conditions from #BV to #PelvicInflammatoryDisease and #Infertility. Learn more about your vaginal microbiome at: https://t.co/SsFndFGxhL.

[celldom @CelldomInc]

Attending @SynBioBeta 2020 tomorrow? Celldom is a finalist in the Startup Draft from 2:15-3:00PM PT on Tuesday September 29. Come and meet Zach, Ben, and Kris. They'll be sharing investment, partnership, and early platform access opportunities. #SynBioBeta2020

[Eric Topol @EricTopol]

Did monoclonal antibodies save the President's life?
We'll never know, but it's possible and the implications are profound.
Let me explain 1/